Concepedia

Darren Sigal

DS

24

Publications

3.7K

Citations

17

H-Index

1997

Active since

Affiliations

Scripps Clinic(Current)

University of Michigan

Dana-Farber Cancer Institute

University of Colorado Anschutz Medical Campus

Scripps Clinic Medical Group

Darren Sigal is an author at Scripps Clinic specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1997–2022

24

Publications

24

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares et al. · The Lancet Oncology · 2019 · 1.7K citations · Full text

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma

Sunil R. Hingorani, Lei Zheng, Andrea J. Bullock et al. · Journal of Clinical Oncology · 2017 · 467 citations

, , +17

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

Eric Van Cutsem, Margaret A. Tempero, Darren Sigal et al. · Journal of Clinical Oncology · 2020 · 404 citations · Full text

In vivo targeting of B-cell lymphoma with glycan ligands of CD22

Weihsu C. Chen, Gladys C. Completo, Darren Sigal et al. · Blood · 2010 · 205 citations · Full text

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Mitesh J. Borad, Shantan Reddy, Nathan Bahary et al. · Journal of Clinical Oncology · 2014 · 186 citations · Full text

Rows per page

1–5 of 24